BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2537883)

  • 1. Lack of serum antibodies to the major HSV-2 specified DNA-binding protein before diagnosis of cervical neoplasia.
    Lehtinen M; Hakama M; Knekt P; Heinonen PK; Lehtinen T; Paavonen J; Teppo L; Leinikki P
    J Med Virol; 1989 Feb; 27(2):131-6. PubMed ID: 2537883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antibodies to the major HSV-2-specified DNA-binding protein in patients with an acute HSV infection or cervical neoplasia.
    Lehtinen M; Lehtinen T; Koivisto V; Paavonen J; Leinikki P
    J Med Virol; 1985 Jul; 16(3):245-56. PubMed ID: 2993495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of association of herpes simplex virus and human papillomavirus infection with cervical neoplasia in women exposed to diethylstilbestrol in utero.
    Adam E; Kaufman RH; Adler-Storthz K; Melnick JL; Dreesman GR
    Int J Cancer; 1985 Jan; 35(1):19-26. PubMed ID: 2981778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment.
    Vonka V; Kanka J; Hirsch I; Závadová H; Krcmár M; Suchánková A; Rezácová D; Broucek J; Press M; Domorázková E
    Int J Cancer; 1984 Jan; 33(1):61-6. PubMed ID: 6319297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSV-IgA serum antibodies in cervical intraepithelial neoplasia and invasive cancer patients, and in their spouses: a case control study.
    Gupta MM; Jain R; Parashari A; Singh V; Satyanarayana L
    APMIS; 1992 Jul; 100(7):598-604. PubMed ID: 1322678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre- and posttreatment serum antibody responses to HPV 16 E2 and HSV 2 ICP8 proteins in women with cervical carcinoma.
    Lehtinen M; Leminen A; Kuoppala T; Tiikkainen M; Lehtinen T; Lehtovirta P; Punnonen R; Vesterinen E; Paavonen J
    J Med Virol; 1992 Jul; 37(3):180-6. PubMed ID: 1331306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls.
    Gilman SC; Docherty JJ; Clarke A; Rawls WE
    Cancer Res; 1980 Dec; 40(12):4640-7. PubMed ID: 6254649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of herpes simplex virus antibody status in women with cervical intraepithelial neoplasia (CIN).
    Coleman DV; Morse AR; Beckwith P; Anderson MC; Gardner SD; Knowles WA; Skinner GR
    Br J Obstet Gynaecol; 1983 May; 90(5):421-7. PubMed ID: 6303385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study on the relationship between cervical neoplasia and herpes simplex type 2 virus. III. Presence of herpes simplex type-2 antibody in sera of subjects who developed cervical neoplasia later in the study.
    Krcmár M; Suchánková A; Kanka J; Vonka V
    Int J Cancer; 1986 Aug; 38(2):161-5. PubMed ID: 3015805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison.
    Dale GE; Coleman RM; Best JM; Benetato BB; Drew NC; Chinn S; Papacosta AO; Nahmias AJ
    Epidemiol Infect; 1988 Jun; 100(3):445-65. PubMed ID: 2837405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups.
    Anzai T; Dreesman GR; Courtney RJ; Adam E; Rawls WE; Benyesh-Melnick M
    J Natl Cancer Inst; 1975 May; 54(5):1051-9. PubMed ID: 165303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens in patients with cervical carcinoma.
    Qvigstad E; Onsrud M; Degré M; Skaug K
    Gynecol Oncol; 1985 Feb; 20(2):184-9. PubMed ID: 2982703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer. II. Antibodies to surface antigen of Herpes simplex virus infected cells.
    Christenson B; Espmark A
    Int J Cancer; 1976 Mar; 17(3):318-25. PubMed ID: 176115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological reactivity of human sera with individual herpes simplex proteins: a comparative study of sera from patients with preinvasive or invasive cervical cancer and from controls.
    Teglbjaerg CS; Feldborg R; Norrild B
    J Med Virol; 1986 Feb; 18(2):169-80. PubMed ID: 3005489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia.
    Rocha-Zavaleta L; Jordan D; Pepper S; Corbitt G; Clarke F; Maitland NJ; Sanders CM; Arrand JR; Stern PL; Stacey SN
    Br J Cancer; 1997; 75(8):1144-50. PubMed ID: 9099962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to Herpes simplex virus types 1 and 2 in patients with squamous-cell carcinoma of uterine cervix in India.
    Seth P; Prakash SS; Ghosh D
    Int J Cancer; 1978 Dec; 22(6):708-14. PubMed ID: 214407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
    Feorino PM; Palmer EL
    J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of serum antibodies to LA-1 oncoprotein, herpes simplex virus type-2 glycoprotein and human papillomavirus type 16 transactivator (E2) protein among Indian women with cervical neoplasia.
    Sharma BK; Sharma R; Smith CC; Aurelian L
    Indian J Exp Biol; 1998 Oct; 36(10):967-72. PubMed ID: 10356958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
    Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE
    Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibodies to herpesvirus early antigens in patients with cervical carcinoma determined by anticomplement immunofluorescence technique.
    Ito H; Tsutsui F; Kurihara S; Akabayashi T; Tobe T
    Int J Cancer; 1976 Nov; 18(5):557-63. PubMed ID: 62718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.